Empresa Corvus Pharmaceuticals, Inc.
Acciones
CRVS
US2210151005
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,92 USD | +10,98 % | +32,41 % | +9,09 % |
Resumen de negocios
Número de empleados: 28
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27/01/14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27/01/14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21/07/22 |
Gabriel Luciano
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/18 |
Chief Tech/Sci/R&D Officer | - | 01/01/19 | |
William Jones
PRN | Corporate Officer/Principal | 59 | - |
Jeffrey Arcara
PRN | Corporate Officer/Principal | - | 06/02 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27/01/14 |
Ian Clark
BRD | Director/Board Member | 62 | 03/01/17 |
Terry Gould
BRD | Director/Board Member | 67 | 01/11/14 |
Peter Thompson
FOU | Founder | 64 | 27/01/14 |
Linda Grais
BRD | Director/Board Member | 68 | 28/01/19 |
Scott Morrison
BRD | Director/Board Member | 66 | 01/12/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 49 038 582 | 43 846 630 ( 89,41 %) | 0 | 89,41 % |
Información de la empresa
Corvus Pharmaceuticals, Inc.
863 Mitten Road Suite 102
94010, Burlingame
+650 900 4520
http://www.corvuspharma.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,09 % | 94,15 M | |
+25,69 % | 47,86 mil M | |
+46,90 % | 41,42 mil M | |
-3,46 % | 40,66 mil M | |
-6,20 % | 28,92 mil M | |
+9,17 % | 25,55 mil M | |
-20,42 % | 19,27 mil M | |
+0,17 % | 12,15 mil M | |
+28,07 % | 12,14 mil M | |
-1,24 % | 11,99 mil M |
- Bolsa de valores
- Acciones
- Acción CRVS
- Empresa Corvus Pharmaceuticals, Inc.